Cargando…
Oncolytic Adenovirus: Prospects for Cancer Immunotherapy
Immunotherapy has moved to the forefront of modern oncologic treatment in the past few decades. Various forms of immunotherapy currently are emerging, including oncolytic viruses. In this therapy, viruses are engineered to selectively propagate in tumor cells and reduce toxicity for non-neoplastic t...
Autores principales: | Zhao, Yaqi, Liu, Zheming, Li, Lan, Wu, Jie, Zhang, Huibo, Zhang, Haohan, Lei, Tianyu, Xu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334181/ https://www.ncbi.nlm.nih.gov/pubmed/34367111 http://dx.doi.org/10.3389/fmicb.2021.707290 |
Ejemplares similares
-
Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis
por: Zhao, Yaqi, et al.
Publicado: (2022) -
Oncolytic Adenovirus in Cancer Immunotherapy
por: Peter, Malin, et al.
Publicado: (2020) -
Oncolytic adenovirus programmed by synthetic gene circuit for cancer immunotherapy
por: Huang, Huiya, et al.
Publicado: (2019) -
Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
por: Hoare, Joseph, et al.
Publicado: (2018) -
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
por: Martín-Carrasco, Clara, et al.
Publicado: (2022)